腹腔热灌注化疗(HIPEC):我们是否应更仔细地审视微环境?
本文综述腹腔热灌注化疗(HIPEC)对卵巢癌微环境的影响及微环境对HIPEC疗效的反作用,探讨微环境是否为其疗效欠佳的关键。HIPEC在卵巢癌中的疗效近期才在随机对照试验中得到证实,但治疗效果并非革命性,上皮性卵巢癌死亡率仍高。
要点
- 上皮性卵巢癌与健康旁观细胞的相互作用已成为治疗靶点。
- HIPEC在卵巢癌中的疗效近期在随机对照试验中得到证实。
- HIPEC的治疗效果并非革命性,上皮性卵巢癌死亡率仍高。
核心结论
- 本文通过综述HIPEC对微环境的影响及微环境对HIPEC的反作用,探讨微环境是否为HIPEC疗效欠佳的关键。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 上皮性卵巢癌与健康旁观细胞相互作用并利用其营养、免疫、播散等能力。
- HIPEC在卵巢癌中的疗效近期才在随机对照试验中得到证实。
- HIPEC的治疗效果并非革命性,上皮性卵巢癌死亡率仍高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The age of cancer as an isolated single-cell concept is now behind us. It is now established that epithelial ovarian cancer, like other cancers, interacts with the healthy bystander cells to influence them and takes advantage of their nutritional, immunological, disseminating and other capacities. This interaction has become a therapeutic target, as shown by the numerous studies on this subject. Intraperitoneal chemo-hyperthermia has been part of the therapeutic armamentarium for some time yet its efficiency in ovarian cancer has only been recently proven in a randomized controlled trial. However, its therapeutic performance is not revolutionary and epithelial ovarian cancer maintains a high mortality. In this review, we studied the impact of HIPEC on the microenvironment and vice versa to determine whether it could be the key to this lukewarm efficacy. We began by exploring the modalities of HIPEC and establishing the reasons that make this treatment topical. Then, we examined its impact on each element of the tumor environment to obtain a global view of the resistance mechanisms at work in HIPEC.
引用
- Crestani A, Benoit L, Touboul C, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment? Gynecol Oncol. 2020. PMID: 32732012. doi:10.1016/j.ygyno.2020.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。